"Anaphylaxis may start out as relatively mild but, if not treated promptly, symptoms can become life-threatening in a short amount of time," the FDA said.
Shares of Biocon gained over 8 per cent after the US Food and Drug Administration (USFDA) classified its Bengaluru unit as ...